Ariel Zell is an associate in the Corporate and Securities Practice Group in the New York office of Haynes and Boone, LLP. His practice focuses on mergers and acquisitions, public and private securities offerings, venture capital investments and other strategic transactions in a broad range of industries. Ariel also advises clients on general corporate, securities compliance and reporting matters.

Selected Client Representations

• Represented an Israel-based bio-technology company in its $11 million private placement transaction.
• Represented a Brazilian business technology company in its acquisition of a U.S.-based identification card manufacturer.
• Represented a venture capital fund in its initial financing of a mobile photograph start-up company.
• Represented a regional power company in its $3.5 billion strategic merger.
• Represented an international pharmaceutical company in its $68 billion strategic acquisition.
• Represented the special committee of the board of directors of a national restaurant chain in the sale of the company to management.
• Represented a healthcare-dedicated investment firm in its Series A financing of a biotech company focusing on the development of therapeutic antibodies.
• Represented a privately held family company in its tender offer for all outstanding common stock of a regional oil and gas company.
• Represented an international chemical company in its offering of $2.75 billion high yield notes and $3.25 billion bankruptcy plan roll-up notes, as part of its exit financing.
• Represented an international building materials company in its $450 million 144A/Regulation S private placement of unsecured notes.

Prior to joining Haynes and Boone, Ariel was an associate in the corporate department of Cadwalader, Wickersham & Taft LLP.

Selected Representative Experience

Online Publications